⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Kairos Pharma, Ltd.

$0.5488
-0.0051 (-0.92%)

Volume:

14.939K ($8.17K)

Market Capitalization:

$1.86M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Kairos Pharma, Market Segments

Regular Trading Hours

+0.0237(+4.51%)
Open$0.5251
Close$0.5488
Low$0.5251
Low Change0.0000 (0.00%)
High$0.5530
High Change+0.0279 (+5.31%)
Range$0.0279
Volume12.889K
Dollar Volume$7.07K

Premarket

+0.0214(+4.16%)
Open$0.5150
Close$0.5364
Low$0.5150
Low Change0.0000 (0.00%)
High$0.5582
High Change+0.0432 (+8.39%)
Range$0.0432
Volume2.05K
Dollar Volume$1.10K

Overnight

*No Trades in Segment

After Hours Yesterday

+0.0112(+2.09%)
Open$0.5361
Close$0.5473
Low$0.5361
Low Change0.0000 (0.00%)
High$0.5473
High Change+0.0112 (+2.09%)
Range$0.0112
Volume343
Dollar Volume$187.72

Regular Trading Hours Yesterday

-0.0172(-3.01%)
Open$0.5711
Close$0.5539
Low$0.5300
Low Change-0.0411 (-7.20%)
High$0.5800
High Change+0.0089 (+1.56%)
Range$0.0500
Volume61.564K
Dollar Volume$34.10K

Premarket Yesterday

-0.0067(-1.22%)
Open$0.5470
Close$0.5403
Low$0.5403
Low Change-0.0067 (-1.22%)
High$0.5470
High Change+0.0000 (+0.00%)
Range$0.0067
Volume532
Dollar Volume$287.44

Kairos Pharma, News

There is no current news for this stock at the moment.

Kairos Pharma, Top Trades

Kairos Pharma,'s top trade so far today returned +8.39%, while the top short trade returned -5.93%.

Kairos Pharma, Moving Averages

5 Day Moving Average (SMA5)$0.5633
10 Day Moving Average (SMA10)$0.6228
20 Day Moving Average (SMA20)$0.9409
50 Day Moving Average (SMA50)$1.0989
100 Day Moving Average (SMA100)$0.7331
200 Day Moving Average (SMA200)$0.6730

Kairos Pharma, Statistics

Average Volume (30 Days)679.16K
P/E Ratio (Current)-.47
EPS (Current)-$1.71
Dividend Yield0.00%
Free Cash Flow-$3.97M
Cash Ratio9.91
Current Ratio11.98
Quick Ratio11.98
Debt to Equity0.00
Enterprise Value$116.16K
EV to EBITDA-0.02
EV to Sales—
Price to Book0.65
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-1.30%
Return on Equity-1.39%

Kairos Pharma, Stock Splits

There has been 1 stock split for Kairos Pharma, (KAPA). The reverse stock split occured on September 1, 2026 and reduced the outstanding shares at a ratio of 7:1.

DateTypeRatio
Sep 1, 2026Reverse7:1

Kairos Pharma, Dividends

There have been no dividends for Kairos Pharma, (KAPA).